Cargando…
Intraovarian platelet-rich plasma administration could improve blastocyst euploidy rates in women undergoing in vitro fertilization
OBJECTIVE: Platelet-rich plasma (PRP) therapy has received a considerable attention as an adjunct to fertility treatments, especially in women with very low ovarian reserve and premature ovarian insufficiency. Although recent studies have demonstrated that PRP led to improvements in folliculogenesis...
Autores principales: | Merhi, Zaher, Seckin, Serin, Mouanness, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Reproductive Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468693/ https://www.ncbi.nlm.nih.gov/pubmed/36097737 http://dx.doi.org/10.5653/cerm.2021.05057 |
Ejemplares similares
-
Intraovarian Platelet-rich Plasma Administration Induced Spontaneous Ovulation in an Anovulatory Woman With PCOS
por: Merhi, Zaher, et al.
Publicado: (2023) -
RACIAL DISPARITY IN HEALTHCARE EXPERIENCE AMONG PATIENTS SEEKING FERTILITY CARE DURING THE COVID-19 PANDEMIC
por: Mouanness, Marco, et al.
Publicado: (2022) -
Logistic regression analyses of factors affecting the euploidy of blastocysts undergoing in vitro fertilization and preimplantation genetic testing
por: Zhang, Zhiping, et al.
Publicado: (2022) -
A Case of Asthenozoospermia Following COVID-19 Infection
por: Seckin, Serin, et al.
Publicado: (2022) -
Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon?
por: Atkinson, Lloyd, et al.
Publicado: (2021)